Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yongshenghe Ejiao is a Traditional Chinese Medicine (TCM) herbal compound developed and manufactured by Beijing Tongrentang. Its primary active component is donkey-hide gelatin (Ejiao), supplemented with various botanical extracts including Rehmannia, Angelica, and Astragalus. It is indicated for the treatment of blood deficiency and, specifically, tumor-related anemia (cancer-related anemia). The formulation works by stimulating the hematopoietic system, increasing hemoglobin levels, and improving the quality of life for cancer patients experiencing treatment-induced or disease-related anemia. It is a marketed product in China and has been the subject of real-world clinical studies to validate its efficacy in oncology supportive care.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yongshenghe ejiao.